Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.77)
# 574
Out of 4,377 analysts
359
Total ratings
44.7%
Success rate
21.6%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDXS Codexis | Maintained: Buy | $11 | $2.56 | +329.69% | 9 | May 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Buy | $84 → $96 | $21.91 | +338.16% | 15 | May 20, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $109 | $59.78 | +82.34% | 9 | May 14, 2026 | |
| CAPR Capricor Therapeutics | Maintained: Buy | $62 | $26.71 | +132.12% | 13 | May 12, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | $16 | $6.70 | +138.81% | 2 | May 12, 2026 | |
| MREO Mereo BioPharma Group | Maintained: Buy | $3 | $0.3132 | +857.85% | 10 | May 12, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $125 | $67.00 | +86.57% | 17 | May 12, 2026 | |
| ESPR Esperion Therapeutics | Downgraded: Hold | $9 → $3.16 | $3.13 | +0.96% | 6 | May 1, 2026 | |
| DBVT DBV Technologies | Maintained: Buy | $48 | $16.59 | +189.33% | 7 | Apr 30, 2026 | |
| RNAC Cartesian Therapeutics | Maintained: Buy | $16 | $5.84 | +173.97% | 9 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $124 | $70.97 | +74.72% | 22 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.48 | $8.33 | +217.83% | 8 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.37 | +334.78% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $7.97 | +276.41% | 12 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $5.50 | +245.45% | 19 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $24 | $3.69 | +550.41% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $21 | $15.75 | +33.33% | 27 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.7332 | +172.78% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 | $29.93 | +26.96% | 13 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $9 | $26.45 | -65.97% | 11 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $11 | $3.93 | +179.90% | 4 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $28.62 | +134.10% | 24 | Mar 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $44.76 | +40.75% | 9 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $5.47 | +412.35% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $10.61 | +126.20% | 8 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $10.13 | +186.28% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.83 | +265.54% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.35 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.03 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.19 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.7767 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $9.35 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.08 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $21.07 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.77 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 → $28 | $0.08 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.000001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.72 | n/a | 4 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.25 → $10 | $1.82 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $0.696 | n/a | 2 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $7.89 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.28 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.67 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0014 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.619 | n/a | 1 | Nov 30, 2020 |
Codexis
May 20, 2026
Maintained: Buy
Price Target: $11
Current: $2.56
Upside: +329.69%
Ultragenyx Pharmaceutical
May 20, 2026
Rated: Buy
Price Target: $84 → $96
Current: $21.91
Upside: +338.16%
Monopar Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $109
Current: $59.78
Upside: +82.34%
Capricor Therapeutics
May 12, 2026
Maintained: Buy
Price Target: $62
Current: $26.71
Upside: +132.12%
Solid Biosciences
May 12, 2026
Maintained: Buy
Price Target: $16
Current: $6.70
Upside: +138.81%
Mereo BioPharma Group
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3132
Upside: +857.85%
Disc Medicine
May 12, 2026
Maintained: Buy
Price Target: $125
Current: $67.00
Upside: +86.57%
Esperion Therapeutics
May 1, 2026
Downgraded: Hold
Price Target: $9 → $3.16
Current: $3.13
Upside: +0.96%
DBV Technologies
Apr 30, 2026
Maintained: Buy
Price Target: $48
Current: $16.59
Upside: +189.33%
Cartesian Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $16
Current: $5.84
Upside: +173.97%
Apr 28, 2026
Maintained: Buy
Price Target: $124
Current: $70.97
Upside: +74.72%
Mar 31, 2026
Maintained: Buy
Price Target: $26.48
Current: $8.33
Upside: +217.83%
Mar 30, 2026
Maintained: Buy
Price Target: $19
Current: $4.37
Upside: +334.78%
Mar 25, 2026
Downgraded: Hold
Price Target: $30
Current: $7.97
Upside: +276.41%
Mar 24, 2026
Maintained: Buy
Price Target: $19
Current: $5.50
Upside: +245.45%
Mar 19, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $3.69
Upside: +550.41%
Mar 16, 2026
Maintained: Hold
Price Target: $14 → $21
Current: $15.75
Upside: +33.33%
Mar 10, 2026
Maintained: Hold
Price Target: $2
Current: $0.7332
Upside: +172.78%
Mar 3, 2026
Maintained: Hold
Price Target: $38
Current: $29.93
Upside: +26.96%
Mar 2, 2026
Downgraded: Hold
Price Target: $55 → $9
Current: $26.45
Upside: -65.97%
Mar 2, 2026
Maintained: Buy
Price Target: $8 → $11
Current: $3.93
Upside: +179.90%
Mar 1, 2026
Maintained: Buy
Price Target: $67
Current: $28.62
Upside: +134.10%
Feb 24, 2026
Maintained: Buy
Price Target: $63
Current: $44.76
Upside: +40.75%
Feb 23, 2026
Maintained: Buy
Price Target: $28
Current: $5.47
Upside: +412.35%
Feb 11, 2026
Maintained: Buy
Price Target: $24
Current: $10.61
Upside: +126.20%
Jan 13, 2026
Maintained: Buy
Price Target: $29
Current: $10.13
Upside: +186.28%
Nov 21, 2025
Maintained: Buy
Price Target: $14
Current: $3.83
Upside: +265.54%
Jul 1, 2024
Maintained: Buy
Price Target: $6 → $7
Current: $1.35
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $4.03
Upside: n/a
Feb 4, 2024
Maintained: Buy
Price Target: $6
Current: $1.19
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.7767
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $9.35
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $27
Current: $1.08
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $21.07
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.77
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $3.5 → $28
Current: $0.08
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.72
Upside: n/a
Dec 21, 2022
Maintained: Hold
Price Target: $4.25 → $10
Current: $1.82
Upside: n/a
Aug 4, 2022
Downgraded: Hold
Price Target: $14 → $11
Current: $0.696
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $7.89
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.28
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $10
Current: $0.67
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0014
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.619
Upside: n/a